Untersuchung rekombinanter Modifizierter Vacciniaviren Ankara hinsichtlich ihrer Eignung als Hendra-Virus-spezifische Impfstoffkandidaten
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Deutsch
- Anmerkungen
-
München, Ludwig-Maximilians-Universität, Dissertation, 2016
- Klassifikation
-
Landwirtschaft, Veterinärmedizin
- Schlagwort
-
Viren
Impfstoff
Ankara
- Ereignis
-
Veröffentlichung
- (wo)
-
München
- (wer)
-
Universitätsbibliothek der Ludwig-Maximilians-Universität
- (wann)
-
2016
- Urheber
-
Resch, Martina
- Beteiligte Personen und Organisationen
-
Sutter, Gerd
- URN
-
urn:nbn:de:bvb:19-229214
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:45 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Resch, Martina
- Sutter, Gerd
- Universitätsbibliothek der Ludwig-Maximilians-Universität
Entstanden
- 2016
Ähnliche Objekte (12)
Herstellung und Untersuchung rekombinanter Modifizierter Vacciniaviren Ankara zur Expression von Antigenen des Felinen Panleukopenievirus
Characterization of recombinant Modified Vaccinia virus Ankara delivering African swine fever virus proteins
Untersuchungen von rekombinantem Modifizierten Vacciniavirus Ankara zur Verabreichung von Antigenen des West-Nil-Virus
Characterization of recombinant Modified Vaccinia virus Ankara delivering Zika virus nonstructural proteins NS2B and NS3pro
Characterization of a recombinant Modified Vaccinia Virus Ankara encoding a novel synthetic immunogen of human cytomegalovirus
Characterization of recombinant Modified Vaccinia virus Ankara expressing the Middle East respiratory syndrome coronavirus nucleocapsid protein
Repair of the Vaccinia virus genes B2R and B3R inhibits interferon production uponmodified Vaccinia virus Ankara infection
Improving the cellular immunogenicity of recombinant Modified Vaccinia virus Ankara using green fluorescent protein as model system
Characterization of a recombinant Modified Vaccinia virus Ankara expressing the severe acute respiratory syndrome virus 2 spike protein
Characterization of fetal protection by vaccination with recombinant Modified Vaccinia virus Ankara in a Zika virus mouse model
Leukocyte trafficking during infection with modified vaccinia virus Ankara : the role of chemokine receptor 1 and complement activation
Characterization of recombinant Modified Vaccinia virus Ankara for delivery of Middle East Respiratory Syndrome Coronavirus spike protein antigens
Herstellung und Untersuchung rekombinanter Modifizierter Vacciniaviren Ankara zur Expression von Antigenen des Felinen Panleukopenievirus
Characterization of recombinant Modified Vaccinia virus Ankara delivering African swine fever virus proteins
Untersuchungen von rekombinantem Modifizierten Vacciniavirus Ankara zur Verabreichung von Antigenen des West-Nil-Virus
Characterization of recombinant Modified Vaccinia virus Ankara delivering Zika virus nonstructural proteins NS2B and NS3pro
Characterization of a recombinant Modified Vaccinia Virus Ankara encoding a novel synthetic immunogen of human cytomegalovirus
Characterization of recombinant Modified Vaccinia virus Ankara expressing the Middle East respiratory syndrome coronavirus nucleocapsid protein
Repair of the Vaccinia virus genes B2R and B3R inhibits interferon production uponmodified Vaccinia virus Ankara infection
Improving the cellular immunogenicity of recombinant Modified Vaccinia virus Ankara using green fluorescent protein as model system
Characterization of a recombinant Modified Vaccinia virus Ankara expressing the severe acute respiratory syndrome virus 2 spike protein
Characterization of fetal protection by vaccination with recombinant Modified Vaccinia virus Ankara in a Zika virus mouse model
Leukocyte trafficking during infection with modified vaccinia virus Ankara : the role of chemokine receptor 1 and complement activation
Characterization of recombinant Modified Vaccinia virus Ankara for delivery of Middle East Respiratory Syndrome Coronavirus spike protein antigens
Herstellung und Untersuchung rekombinanter Modifizierter Vacciniaviren Ankara zur Expression von Antigenen des Felinen Panleukopenievirus
Characterization of recombinant Modified Vaccinia virus Ankara delivering African swine fever virus proteins
Untersuchungen von rekombinantem Modifizierten Vacciniavirus Ankara zur Verabreichung von Antigenen des West-Nil-Virus
Characterization of recombinant Modified Vaccinia virus Ankara delivering Zika virus nonstructural proteins NS2B and NS3pro
Characterization of a recombinant Modified Vaccinia Virus Ankara encoding a novel synthetic immunogen of human cytomegalovirus
Characterization of recombinant Modified Vaccinia virus Ankara expressing the Middle East respiratory syndrome coronavirus nucleocapsid protein
Repair of the Vaccinia virus genes B2R and B3R inhibits interferon production uponmodified Vaccinia virus Ankara infection
Improving the cellular immunogenicity of recombinant Modified Vaccinia virus Ankara using green fluorescent protein as model system
Characterization of a recombinant Modified Vaccinia virus Ankara expressing the severe acute respiratory syndrome virus 2 spike protein
Characterization of fetal protection by vaccination with recombinant Modified Vaccinia virus Ankara in a Zika virus mouse model
Leukocyte trafficking during infection with modified vaccinia virus Ankara : the role of chemokine receptor 1 and complement activation